Health Care & Life Sciences » Pharmaceuticals | Sunflower Pharmaceuticals Group Co. Ltd.

Sunflower Pharmaceuticals Group Co. Ltd. | Income Statement

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
2,152
2,662
2,983
3,289
3,787
4,397
Cost of Goods Sold (COGS) incl. D&A
808
1,063
1,380
1,424
1,601
1,881
Gross Income
1,345
1,599
1,603
1,865
2,186
2,517
SG&A Expense
988
1,164
1,254
1,482
1,680
1,875
EBIT
344
415
333
412
504
655
Unusual Expense
-
-
-
-
2
10
Non Operating Income/Expense
-
1
1
1
62
32
Interest Expense
39
34
19
12
11
7
Pretax Income
347
407
401
422
565
720
Income Tax
64
76
74
83
95
113
Consolidated Net Income
283
331
328
339
470
608
Net Income
263
301
307
303
424
563
Net Income After Extraordinaries
263
301
307
303
424
563
Net Income Available to Common
263
301
307
303
424
563
EPS (Basic)
0.45
0.69
0.53
0.52
0.73
0.96
Basic Shares Outstanding
584
438
584
584
584
584
EPS (Diluted)
0.45
0.69
0.52
0.52
0.73
0.96
Diluted Shares Outstanding
584
438
584
584
584
584
EBITDA
366
488
425
527
649
801
Other Operating Expense
13
20
16
29
2
13
Non-Operating Interest Income
2
2
26
8
11
17
Minority Interest Expense
20
30
21
36
46
45

About Sunflower Pharmaceuticals Group Co.

View Profile
Address
No. 18 Donghu Road, Jizhong Area
Harbin Heilongjiang 150078
China
Employees -
Website http://www.kuihuayaoye.com
Updated 07/08/2019
Sunflower Pharmaceutical Group Co., Ltd. engages in the research and development, manufacturing, and marketing of pharmaceutical products. It focuses on proprietary Chinese medicines, chemical drugs, bio-pharmaceuticals, and tonic health care products. Its products include children's medication, digestive system medication, respiratory and cold medicine, gynecological drugs, rheumatism bone disease medication, and cardiovascular and cerebrovascular drugs.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.